Figure 1  .

Negative correlation between the basal activities of calcineurin in the peripheral blood mononuclear cells (PBMC) of patients with systemic lupus erythematosus (SLE) and the doses of glucocorticosteroids (GCS) used for treatment. The coefficient of correlation between the basal calcineurin activities in the PBMC and the daily doses of GCS (0-32 mg/day) taken by patients with SLE was calculated. The calcineurin activity of healthy controls were taken as 100%. The number of patients is given in parentheses.